文献速递脊柱关节炎

脊柱关节炎服务:患者与风湿免疫科医生的调查

Services for spondyloarthritis: a survey of patients and rheumatologists.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

该研究通过在线患者调查(英国国家强直性脊柱炎协会会员,1979份可分析问卷,56%为男性)和面向英国全部172家急性医院信托风湿免疫科医生的网络问卷,评估中轴型脊柱关节炎(axSpA)风湿免疫服务现状及患者对诊疗的感受;患者对风湿免疫诊疗满意度高,但存在疾病发作期就医可及性和镇痛药不良反应等未满足需求,服务提供存在差异;作者认为这些信息将用于制定axSpA质量标准。

要点

  • 82%的受访患者目前就诊于风湿免疫科医生,43%正在使用生物制剂。
  • 仅44%的受访患者知晓「中轴型脊柱关节炎(axSpA)」这一术语。
  • 88%的受访风湿免疫科医生接受axSpA概念与术语,62%的中心至少有1名对axSpA有专门兴趣的医生。

核心结论

  • 尽管患者对风湿免疫诊疗的总体满意度高,但结果提示患者存在显著未满足需求且服务提供存在差异。
  • 作者认为这些信息将用于制定axSpA质量标准,以改善质量并为所有患者提供公平诊疗。

研究设计与样本

  • 患者调查:在线问卷通过电子邮件发送给英国国家强直性脊柱炎协会全体会员,并通过社交媒体广泛宣传,1979份问卷数据可分析(56%为男性)。
  • 风湿免疫科医生调查:网络问卷发送至英国全部172家急性医院信托的风湿免疫科医生。

主要发现

  • 多数受访患者为长期病程并将诊断认定为强直性脊柱炎(AS),仅44%知晓「中轴型脊柱关节炎(axSpA)」术语。
  • 82%的受访患者目前就诊于风湿免疫科医生,43%正在使用生物制剂;受访者对风湿免疫诊疗的满意度评分高。
  • 患者关注的问题包括疾病发作期就医可及性和镇痛药的不良反应。
  • 88%的受访风湿免疫科医生接受axSpA概念与术语;62%的中心至少有1名对axSpA有专门兴趣的医生,58%有专门的axSpA门诊,64%有axSpA多学科团队。
  • BASDAI(99%)、BASFI(74%)和BASMI(65%)被常规执行;所有中心均可获得MRI扫描,但扫描方案不一且常欠佳。

关键数值与推荐

  • BASDAI在99%的中心常规执行,BASFI为74%,BASMI为65%。
  • 88%的受访风湿免疫科医生接受axSpA概念与术语;62%的中心至少有1名对axSpA有专门兴趣的医生,58%有专门的axSpA门诊,64%有axSpA多学科团队。
  • 82%的受访患者目前就诊于风湿免疫科医生,43%正在使用生物制剂,44%知晓「中轴型脊柱关节炎(axSpA)」术语。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There have been significant advances in axial spondyloarthritis (axSpA), with implications for service delivery. We evaluated the state of axSpA rheumatology services and how people with axSpA perceive their care. METHODS: An online patient survey was emailed to all members of the National Ankylosing Spondylitis Society and advertised widely via social media. Separately, a Web-based questionnaire about axSpA services was sent to rheumatologists at all 172 acute hospital trusts in the UK. RESULTS: From the National Ankylosing Spondylitis Society survey, data for 1979 surveys (56% males) were available for analysis. The majority of respondents had longstanding disease and identified their diagnosis as AS, with only 44% aware of the term axSpA. Eighty-two per cent of respondents were currently attending a rheumatologist, with 43% on biologic agents. Satisfaction scores for rheumatology care were high. Respondents' concerns included access during disease flares and adverse effects of analgesics. From the rheumatology survey, the concept and terminology of axSpA was widely accepted by respondents (88%). The majority of centres had at least one rheumatologist with a specialist interest in axSpA (62%), dedicated axSpA clinics (58%) or a multidisciplinary team for axSpA (64%). BASDAI (99%), BASFI (74%) and BASMI (65%) were routinely performed. All centres had access to MRI scans, but scanning protocols varied and were often sub-optimal. CONCLUSION: Although overall satisfaction with rheumatology care was high, the results indicate significant unmet patient needs and discrepancies in service provision. This information will inform the development of quality standards for axSpA in order to improve quality and deliver equitable care for all patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Derakhshan MH, Pathak H, Cook D, et al. Services for spondyloarthritis: a survey of patients and rheumatologists. Rheumatology (Oxford). 2018. PMID: 29529295. doi:10.1093/rheumatology/kex518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。